IE
GH icon

Israel Englander’s Guardant Health GH Stock Holding History

Israel Englander’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243M Buy
1,622,458
+701,063
+76% +$76.2M 0.09% 186
2026
Q1 		$85.1M Buy
921,395
+337,588
+58% +$33.9M 0.04% 526
2025
Q4 		$59.6M Sell
583,807
-294,769
-34% -$26.4M 0.03% 688
2025
Q3 		$54.9M Sell
878,576
-1,843,305
-68% -$100M 0.02% 802
2025
Q2 		$142M Buy
2,721,881
+1,625,148
+148% +$72.6M 0.07% 266
2025
Q1 		$46.7M Sell
1,096,733
-130,077
-11% -$5.61M 0.02% 820
2024
Q4 		$37.5M Buy
1,226,810
+572,835
+88% +$16.1M 0.02% 992
2024
Q3 		$15M Sell
653,975
-1,481,336
-69% -$41.9M 0.01% 1828
2024
Q2 		$61.7M Buy
2,135,311
+945,328
+79% +$22M 0.03% 675
2024
Q1 		$24.5M Buy
1,189,983
+469,968
+65% +$10.1M 0.01% 1385
2023
Q4 		$19.5M Sell
720,015
-1,999,855
-74% -$52.5M 0.01% 1568
2023
Q3 		$80.6M Buy
2,719,870
+285,692
+12% +$10M 0.04% 462
2023
Q2 		$87.1M Buy
2,434,178
+1,136,756
+88% +$32.6M 0.04% 421
2023
Q1 		$30.4M Buy
1,297,422
+702,866
+118% +$20.1M 0.02% 1013
2022
Q4 		$16.2M Buy
+594,556
New +$27.2M 0.01% 1645
2022
Q2 		– Sell
-6,137
Closed -$407K – 7153
2022
Q1 		$407K Sell
6,137
-28,409
-82% -$1.94M ﹤0.01% 5278
2021
Q4 		$3.46M Sell
34,546
-25,404
-42% -$2.63M ﹤0.01% 3254
2021
Q3 		$7.49M Sell
59,950
-239,359
-80% -$28.4M ﹤0.01% 2407
2021
Q2 		$37.2M Sell
299,309
-47,753
-14% -$6.42M 0.02% 760
2021
Q1 		$53M Buy
347,062
+82,112
+31% +$12.4M 0.04% 463
2020
Q4 		$34.1M Buy
264,950
+64,043
+32% +$7.37M 0.02% 684
2020
Q3 		$22.5K Sell
200,907
-122,363
-38% -$11.2M 0.03% 720
2020
Q2 		$26.2M Buy
+323,270
New +$26M 0.04% 585
2020
Q1 		– Sell
-334,704
Closed -$26.2M – 4080
2019
Q4 		$26.2M Buy
334,704
+207,105
+162% +$14.9M 0.03% 679
2019
Q3 		$8.14M Sell
127,599
-66,676
-34% -$5.87M 0.01% 1428
2019
Q2 		$16.8M Buy
+194,275
New +$14.8M 0.03% 892

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Israel Englander's GH Position: Q2 2026 in Review

Israel Englander increased its Guardant Health (GH) stake by 76% in Q2 2026, buying an estimated $76.2M and bringing the position to 1,622,458 shares worth $243M. The position accounts for 0.09% of the portfolio, ranked #186.

Israel Englander first reported a position in GH in Q2 2019 and has held it in 26 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Israel Englander held 1,622,458 shares of Guardant Health worth $243M as of Q2 2026.
  • Israel Englander bought 701,063 Guardant Health shares in Q2 2026, an estimated $76.2M.
  • Guardant Health made up 0.09% of Israel Englander's portfolio in Q2 2026, its #186 holding.
  • Israel Englander first reported a position in Guardant Health in Q2 2019 and has held it in 26 quarters since.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.